MASIMO CORP - 01 Jul 2025 Form 4 Insider Report for Neuraxis, INC (NRXS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Jul 2025, 17:38:10 UTC
Prior SEC filing
11 Aug 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Micah Young, Attorney-In-Fact

Key filing fact

MASIMO CORP filed Form 4 for Neuraxis, INC (NRXS) on 03 Jul 2025.

Key facts

  • This page summarizes MASIMO CORP's Form 4 filing for Neuraxis, INC (NRXS).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 03 Jul 2025, 17:38.

Change

  • Previous filing in this sequence was filed on 11 Aug 2023.
  • Current net transaction value: -$1,847,957.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0000937556 Primary reporting owner

MASIMO CORP

Relationship
10%+ Owner
Address
52 DISCOVERY, IRVINE
Signature
/s/ Micah Young, Attorney-In-Fact
Signature date
03 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NRXS transaction

Common Stock

Sale

Transaction value
$1,195,983
Shares
-531,548
Change %
-100%
Price
$2.25
Shares after
0
Date
01 Jul 2025
Ownership
Direct
NRXS transaction

Common Stock

Conversion of derivative security

Transaction value
$28.98
Shares
+289,779
Change %
Price
$0.000100
Shares after
289,779
Date
01 Jul 2025
Ownership
Direct
NRXS transaction

Common Stock

Sale

Transaction value
$652,003
Shares
-289,779
Change %
-100%
Price
$2.25
Shares after
0
Date
01 Jul 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NRXS transaction Derivative

Pre-Funded Warrant, Common Stock (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-289,779
Change %
-100%
Price
$0.000000
Shares after
0
Date
01 Jul 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
289,779
Exercise price
$0.000500
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

MASIMO CORP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.0005 per share of the Issuer's Common Stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .